Determinants of human papillomavirus (HPV) vaccine uptake among girls in France: A population-based telephone survey

References

• The French National Cancer Institute. Cancers in France. [accessed 2021 Nov 14]. https://www.e-cancer.fr/ressources/cancers_en_france/#page=117
   Google Scholar
• Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in France. Summary report. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre); 2021. [accessed 2022 May 2]. https://hpvcentre.net/statistics/reports/FRA.pdf
   Google Scholar
• The World Health Organization (WHO). 73rd World Health Assembly Decisions. 2020 Aug 7 [accessed 2022 May 2]. https://www.who.int/news-room/feature-stories/detail/73rd-world-health-assembly-decisions
   Google Scholar
• The French Ministry of Health. The vaccination schedule. [accessed 2021 Nov 14]. https://solidarites-sante.gouv.fr/prevention-en-sante/preserver-sa-sante/vaccination/calendrier-vaccinal
   Google Scholar
• The European Centre for Disease Prevention and Control (ECDC). Vaccine scheduler. 2021 Oct 28 [accessed 2022 May 2]. https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByCountry?SelectedCountryId=76&IncludeChildAgeGroup=true&IncludeChildAgeGroup=false&IncludeAdultAgeGroup=true&IncludeAdultAgeGroup=false
   Google Scholar
• The French Public Health Agency. Human papillomavirus (HPV) vaccination coverage data by age group. 2022 Apr 25 [accessed 2021 Nov 14]. https://www.santepubliquefrance.fr/determinants-de-sante/vaccination/donnees-de-couverture-vaccinale-papillomavirus-humains-hpv-par-groupe-d-age
   Google Scholar
• The French National Cancer Institute. Cancer plan 2014-2019: curing and preventing cancer: let’s give everyone the same chance, everywhere in France. 2015 [accessed 2022 Apr 19]. https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Plan-Cancer-2014-2019
   Google Scholar
• The French High Council for Public Health (HCSP). Summary report of the first mandate of the French High Council for Public Health. 2009 Dec 11 [accessed 2018 Jan 21]. https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=97
   Google Scholar
• The French National Authority for Health (HAS). Cervical cancer: better vaccination coverage and increased screening remain the priority. 2017 Oct 11 [accessed 2018 Jan 28]. https://www.has-sante.fr/portail/jcms/c_2797450/fr/cancer-du-col-de-l-uterus-une-meilleure-couverture-vaccinale-et-un-depistage-renforce-restent-la-priorite
   Google Scholar
• Decree No. 2019-712 of 5 July 2019 on the experiment for the development of vaccination against human papillomavirus infections - legifrance. [accessed 2022 May 5]. https://www.legifrance.gouv.fr/loda/id/LEGITEXT000038736248/
   Google Scholar
• Kessels SJM, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):1–17. doi:10.1016/j.vaccine.2012.03.063.
   Web of Science ®Google Scholar
• Fernández de Casadevante V, Gil Cuesta J, Cantarero-Arévalo L. Determinants in the uptake of the human papillomavirus vaccine: a systematic review based on European studies. Front Oncol. 2015;5:141. doi:10.3389/fonc.2015.00141.
   PubMed Web of Science ®Google Scholar
• Spencer JC, Calo WA, Brewer NT. Disparities and reverse disparities in HPV vaccination: a systematic review and meta-analysis. Prev Med. 2019;123:197–203. doi:10.1016/j.ypmed.2019.03.037.
   PubMed Web of Science ®Google Scholar
• Newman PA, Logie CH, Lacombe-Duncan A, Baiden P, Tepjan S, Rubincam C, Doukas N, Asey F. Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open. 2018;8(4):e019206. doi:10.1136/bmjopen-2017-019206.
   PubMed Web of Science ®Google Scholar
• Guthmann J-P, Pelat C, Célant N, Parent du Chatelet I, Duport N, Rochereau T, Lévy-Bruhl D. Socioeconomic inequalities to accessing vaccination against human papillomavirus in France: results of the health, health care and insurance survey, 2012. Revue D’Epidemiologie Et De Sante Publique. 2017;65(2):109–117. doi:10.1016/j.respe.2017.01.100.
   PubMed Web of Science ®Google Scholar
• Héquet D, Rouzier R, Grce M. Determinants of geographic inequalities in HPV vaccination in the most populated region of France. PloS One. 2017;12(3):e0172906. doi:10.1371/journal.pone.0172906.
   PubMed Web of Science ®Google Scholar
• Lutringer-Magnin D, Cropet C, Barone G, Canat G, Kalecinski J, Leocmach Y, Vanhems P, Chauvin F, Lasset C. HPV vaccination among French girls and women aged 14-23 years and the relationship with their mothers’ uptake of pap smear screening: a study in general practice. Vaccine. 2013;31(45):5243–5249. doi:10.1016/j.vaccine.2013.08.068.
   PubMed Web of Science ®Google Scholar
• Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, Schuster M, MacDonald NE, Wilson R. Measuring vaccine hesitancy: the development of a survey tool. Vaccine. 2015;33(34):4165–4175. doi:10.1016/j.vaccine.2015.04.037.
   PubMed Web of Science ®Google Scholar
• Guzman-Holst A, DeAntonio R, Prado-Cohrs D, Juliao P. Barriers to vaccination in Latin America: a systematic literature review. Vaccine. 2020;38(3):470–481. doi:10.1016/j.vaccine.2019.10.088.
   PubMed Web of Science ®Google Scholar
• MacDonald NE. SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4164. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• The National Institute of Statistics and Economic Studies. Tables of the French economy. 2014 Feb 19 [accessed 2021 Nov 14]. https://www.insee.fr/fr/statistiques/1288326?sommaire=1288404
   Google Scholar
• Tatar O, Shapiro GK, Perez S, Wade K, Rosberger Z. Using the precaution adoption process model to clarify human papillomavirus vaccine hesitancy in Canadian parents of girls and parents of boys. Human Vaccines & Immunotherapeutics. 2019 Feb 8;15(7–8):1803–1814. doi:10.1080/21645515.2019.1575711.
   PubMed Web of Science ®Google Scholar
• Shapiro GK, Tatar O, Amsel R, Prue G, Zimet GD, Knauper B, Rosberger Z. Using an integrated conceptual framework to investigate parents’ HPV vaccine decision for their daughters and sons. Prev Med. 2018;116:203–210. doi:10.1016/j.ypmed.2018.09.017.
   PubMed Web of Science ®Google Scholar
• Larson HJ, de Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, Cook AR, Jones NS. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016;12:295–301. doi:10.1016/j.ebiom.2016.08.042.
   PubMed Web of Science ®Google Scholar
• Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–1379. doi:10.1016/S0895-4356(96)00236-3.
   PubMed Web of Science ®Google Scholar
• Derhy S, Gaillot J, Rousseau S, Piel C, Thorrington D, Zanetti L, Gall B, Venot C, Chyderiotis S, Mueller J. [Extension of HPV vaccination to boys: survey of families and general practitioners]. Bull Cancer. 2022 ;109(4):S0007455122000364. doi:10.1016/j.bulcan.2022.01.005.
   Web of Science ®Google Scholar
• Yankey D, Elam-Evans LD, Bish CL, Stokley SK. Human papillomavirus vaccination estimates among adolescents in the Mississippi delta region: National Immunization Survey ‑ Teen, 2015–2017. Prev Chronic Dis. 2020;17:190234. doi:10.5888/pcd17.190234.
   Web of Science ®Google Scholar
• Bodson J, Ding Q, Warner EL, Hawkins AJ, Henry KA, Kepka D. Sub-Regional assessment of HPV vaccination among female adolescents in the Intermountain West and implications for intervention opportunities. Matern Child Health J. 2017;21(7):1500–1511. doi:10.1007/s10995-017-2274-3.
   PubMed Web of Science ®Google Scholar
• Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, De Angelis S, Takacs J, Ali KA, Pastore Celentano L, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Human Vaccines & Immunotherapeutics, [2019 Jan 11];15(7–8):1615–1627. doi:10.1080/21645515.2018.1564436.
   PubMed Web of Science ®Google Scholar
• Kornides M, Head KJ, Feemster K, Zimet GD, Panozzo CA. Associations between HPV vaccination among women and their 11–14-year-old children. Human Vaccines & Immunotherapeutics. 2019;15(7–8):1824–1830. doi:10.1080/21645515.2019.1625642.
   PubMed Web of Science ®Google Scholar
• Hertweck SP, LaJoie AS, Pinto MD, Flamini L, Lynch T, Logsdon MC. Health care decision making by mothers for their adolescent daughters regarding the quadrivalent HPV vaccine. J Pediatr Adolesc Gynecol. 2013;26(2):96–101. doi:10.1016/j.jpag.2012.10.009.
   PubMed Web of Science ®Google Scholar
• Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123(6):1439–1445. doi:10.1542/peds.2008-1536.
   PubMed Web of Science ®Google Scholar
• Allen JD, de Jesus M, Mars D, Tom L, Cloutier L, Shelton RC. Decision-Making about the HPV vaccine among ethnically diverse parents: implications for health communications. Journal of Oncology. 2012;2012:401979. doi:10.1155/2012/401979.
   PubMedGoogle Scholar